A Study of the Drugs Prexasertib, Irinotecan, and Temozolomide in People With Desmoplastic Small Round Cell Tumor and Rhabdomyosarcoma
Conditions:   Desmoplastic Small Round Cell Tumor;   Rhabdomyosarcoma Interventions:   Drug: Prexasertib;   Drug: Irinotecan;   Drug: Temozolomide Sponsor:   Memorial Sloan Kettering Cancer Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 19, 2019 Category: Research Source Type: clinical trials